Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling

dc.contributor.authorGrammatikos, Alexandros P.
dc.contributor.authorGhosh, Debjani
dc.contributor.authorDevlin, Amy
dc.contributor.authorKyttaris, Vasileios C.
dc.contributor.authorTsokos, George C.
dc.date.accessioned2020-04-02T18:03:21Z
dc.date.available2020-04-02T18:03:21Z
dc.date.issued2013-08-27
dc.description.abstractEngagement of the CD3/T cell receptor complex in systemic lupus erythematosus (SLE) T cells involves Syk rather than the zeta-associated protein. Because Syk is being considered as a therapeutic target we asked whether Syk is central to the multiple aberrantly modulated molecules in SLE T cells. Using a gene expression array, we demonstrate that forced expression of Syk in normal T cells reproduces most of the aberrantly expressed molecules whereas silencing of Syk in SLE T cells normalizes the expression of most abnormally expressed molecules. Protein along with gene expression modulation for select molecules was confirmed. Specifically, levels of cytokine IL-21, cell surface receptor CD44, and intracellular molecules PP2A and OAS2 increased following Syk overexpression in normal T cells and decreased after Syk silencing in SLE T cells. Our results demonstrate that levels of Syk affect the expression of a number of enzymes, cytokines and receptors that play a key role in the development of disease pathogenesis in SLE and provide support for therapeutic targeting in SLE patients.en_US
dc.identifier.doi10.1371/journal.pone.0074550
dc.identifier.urihttp://hdl.handle.net/10342/7778
dc.titleSpleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signalingen_US
dc.typeArticleen_US
ecu.journal.issue8en_US
ecu.journal.namePLoS ONEen_US
ecu.journal.pages1-9en_US
ecu.journal.volume8en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
journal.pone.0074550.PDF
Size:
750.86 KB
Format:
Adobe Portable Document Format
Description:

Collections